Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financials early next week?

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Aug 23, 2022 3:10pm

188 Views

Post# 34915039

RE:Financials early next week?

Eoganacht wrote

Last year the financials came out on Monday, Aug. 30
In 2020 they came out on Friday, August 28

So probably next Monday the 29th or Tuesday the 30th...

All eyes will be on results for those 11 pending at 270 days...

To be clear the 270 day update will be on 24 patients per official news release, patient 25 should also clear as #25 probably received treatment shortly after and still make the 270 day mark. 3 more trading days at best could stretch to 4 but who cares I'm cracking the champaign Friday evening.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario